おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Univercells
company
About
Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions
- 51 - 100
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €50M
- Industries
- Biotechnology,Health Care,Manufacturing
- Founded date
- Jan 1, 2013
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%.Univercells' technologies, aimed at low cost manufacturing of antibodies/proteins/vaccines, is based on single-use technologies, and chaining of three manufacturing steps into simulated continuous mode : cell culture under perfusion, clarification and capture.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€50M
Univercells has raised a total of
€50M
in funding over 2 rounds. Their latest funding was raised on
Feb 18, 2020 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 18, 2020 | Series Unknown | €50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Univercells is funded by 1 investors.
Kohlberg Kravis Roberts
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Kohlberg Kravis Roberts
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
